In addition, 60% of respondents said they know someone who wants to take a GLP-1 but cannot afford to do so
Cardiovascular Risk Markers TRIUMPH-4 also assessed a panel of cardiometabolic biomarkers, and the results were broadly favorable across the board: Non-HDL cholesterol significant reductions, indicating improved atherogenic lipid burden Triglycerides meaningful decreases, consistent with the known effects of GLP-1 and GIP receptor activation on lipid metabolism High-sensitivity C-reactive protein (hsCRP) substantial reductions, reflecting decreased systemic inflammation
Your body shifts fuel usage patterns, reduces appetite signaling, and slows gastric emptyingprocesses that demand energy adaptation
This is a tricky question
Occasionally a protein supplement may be needed to meet protein goals
The STEP TEENS trial (N=201, ages 12, 17) demonstrated that semaglutide 2.4 mg once weekly reduced BMI by 16.1% versus a 0.6% increase with placebo at 68 weeks [11]